Biovotion is a wearable physiology monitoring company. It offers Everion Remote Monitoring, a solution that comprises a medical wearable, an ecosystem, and Augment mobile app. Everion provides continuous medical-grade physiological data, contextual information, and relevant insights for healthcare professionals or researchers.
TypeSubsidiary
Parent CompanyBiofourmis
HQZürich, CH
Founded2011
Websitebiovotion.com
Cybersecurity ratingAMore
Biovotion was founded in 2011 and is headquartered in Zürich, CH
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Biovotion

Markus Christen

Markus Christen

Board Member
Kuldeep Singh Rajput

Kuldeep Singh Rajput

Founder & Chief Executive Officer
Wendou Niu

Wendou Niu

Co-Founder & Chief Privacy Officer
Wolfgang Werner

Wolfgang Werner

Sr.VP Regulatory & Quality
Jaydev Thakkar

Jaydev Thakkar

Chief Operating Officer
Milan Shah

Milan Shah

Chief Technology Officer
Show more

Biovotion Office Locations

Biovotion has an office in Zürich
Zürich, CH (HQ)
Kreuzstrasse 2
Show all (1)

Biovotion Financials and Metrics

Summary Metrics

Founding Date

2011

Total Funding

$13.4 m

Investors

In total, Biovotion had raised $13.4 m. Biovotion is a subsidiary of Biofourmis

Biovotion Operating Metrics

Sep, 2019

Patent Applications

2

Patents Issued

8

Trademarks

2
Show all operating metrics

Biovotion Cybersecurity Score

Cybersecurity ratingPremium dataset

A

92/100

SecurityScorecard logo

Biovotion Online and Social Media Presence

Embed Graph

Biovotion News and Updates

Wireless Vital Signs Monitors Market Share Analysis, By Key Players & Competitive Landscape 2018-2023: Sotera Wireless, Biovotion, Sensium Healthcare

"Wireless Vital Signs Monitors Market", published by Qurate Research, provides extensive insight and analysis of the Wireless Vital Signs Monitors Market over the next eight years (2018-2023) and acts as a vital point of reference for operators or suppliers. Posted via Industry Today. Follow us on T…

Biovotion Blogs

Biofourmis Selected by American College of Cardiology as Exclusive Virtual Care Platform to Drive TRANSFORM(3) Study Focused on Closing Practice Gaps for Heart Conditions

Biofourmis Care, a comprehensive care management platform including virtual multidisciplinary care teams, to be evaluated against in-person care among underserved patients with chronic cardiovascular conditions   BOSTON, May 12, 2022 – Biofourmis, a Boston-based global leader in virtual care and dig…

Biofourmis Receives Significant Growth Investment from General Atlantic to Surpass Unicorn Status

$300M Series D to fund continued growth of Biofourmis’ innovative virtual solutions Dr. Omar Ishrak Appointed Biofourmis Chairman BOSTON, April 26, 2022 – Biofourmis, a global leader in virtual care and digital medicine, today announced it has surpassed unicorn status with a $300 million Series D in…

Blessing Health System Partners with Biofourmis to Launch Home Hospital Services

Leader in virtual care and remote patient management solutions will enable integrated health system serving three states to participate in rural hospital research study and CMS Acute Hospital Care at Home Program   BOSTON, March 30, 2022 – Biofourmis, a Boston-based global leader in virtual care and…

Biofourmis Wins Two 2021 Fierce Healthcare Innovation Awards for Hospital@Home Solution

Comprehensive, turnkey platform that delivers inpatient-level care at home earns recognition for “Digital/Mobile Health Solution” and “Best in Show: Cost Saving” BOSTON, December 13, 2021 – Biofourmis, a Boston-based global leader in digital therapeutics and virtual care that powers personalized pre…

Biofourmis Earns FDA’s First-Ever Breakthrough Device Designation for a Novel Digital Therapeutic for Heart Failure

Biofourmis, a Boston-based global leader in virtual care and digital therapeutics, announced today its BiovitalsHF® solution is the first-ever heart failure digital therapeutic to receive a Breakthrough Device designation from the U.S. Food and Drug Administration (FDA). The post Biofourmis Earns F…

Biovotion AG acquired by Biofourmis AG

An exciting future for Biovotion as part of Biofourmis The Biovotion team is excited to announce the acquisition of Biovotion AG by Biofourmis. Biofourmis is a fast-growing global leader in digital therapeutics based in Boston, Mass., United States. The two companies have been working together over…
Show more

Biovotion Frequently Asked Questions

  • When was Biovotion founded?

    Biovotion was founded in 2011.

  • Who are Biovotion key executives?

    Biovotion's key executives are Markus Christen, Kuldeep Singh Rajput and Wendou Niu.

  • How many employees does Biovotion have?

    Biovotion has 1 employees.

  • Who are Biovotion competitors?

    Competitors of Biovotion include SynPhNe, Alio and LifeSense Group.

  • Where is Biovotion headquarters?

    Biovotion headquarters is located at Kreuzstrasse 2, Zürich.

  • Where are Biovotion offices?

    Biovotion has an office in Zürich.

  • How many offices does Biovotion have?

    Biovotion has 1 office.